Company news
Cizzle Biotechnology Holdings Plc (LSE:CIZ) news
Cizzle Biotechnology Holdings Plc news releases on 6ix. Latest, Mar 30, 2023: Second Price Monitoring Extn
Press releases — page 2
Second Price Monitoring Extn
March 30, 2023
Price Monitoring Extension
March 30, 2023
Issue of Options in lieu of salary increases
March 7, 2023
Update re. timing of Admission
December 20, 2022
Put Option re AZD1656 & £115,586 Subscription
December 19, 2022
Clinical Study for Lung Cancer Detection in China
November 23, 2022
Conduit Pharmaceuticals Proposed Listing
November 9, 2022
Admission and Total Voting Rights
October 4, 2022
Issue of Consideration Shares & Option Exercise
September 29, 2022
Interim results
September 28, 2022
Subscription, Facility & Publication of Prospectus
September 21, 2022
Arcadia Clinical Trial Results Published
August 18, 2022
Cizzle Biotechnology (CIZ): Considerable progre...
July 11, 2022
Update on Development of Proprietary Antibodies
July 5, 2022
Marketing Agreement to Enhance Expansion in the US
June 16, 2022
Results for the year ended 31 December 2021
May 30, 2022
Strategic Alliance re lung cancer detection in USA
May 6, 2022
Further Research Agreement with University of York
April 11, 2022
Positive outcomes from Arcadia Trial re AZD1656
March 7, 2022
Royalty Acquisition Agreement
February 14, 2022
Cizzle Biotechnology (CIZ) Strategic alliance i...
February 8, 2022
China Royalty Agreement for Lung Cancer Detection
February 3, 2022
Cizzle Biotechnology (CIZ): News flow driven by...
December 7, 2021
Lung Cancer Detection Strategic Alliance in China
November 25, 2021
Grant of Options
November 4, 2021
Companion Diagnostic Supply Agreement with SGSC
October 22, 2021
Cizzle Biotechnology (CIZ): Keeping on-track
September 30, 2021
Cizzle Biotechnology (CIZ): Strategic collabora...
September 20, 2021
Agreement with St George Street Capital
September 20, 2021
Encouraging progress on collaboration with SGSC
September 9, 2021
Collaboration with FairJourney Biologics
July 22, 2021
Result of GM
June 29, 2021
GM Statement
June 29, 2021
MOU for the Development of a Companion Diagnostic
June 22, 2021
Change of Company Name
May 27, 2021
Results for the year ended 31 December 2020
May 21, 2021
Cizzle Biotechnology/Bould (CIZ): Early detecti...
May 14, 2021
First Day of Dealings
May 14, 2021